688020-76-0 Usage
Uses
Used in Pharmaceutical Industry:
(S)-2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-butanoic acid is used as a potential therapeutic agent for the treatment of neurological or psychiatric disorders due to its benzodiazepine derivative nature and its various functional groups that may contribute to its pharmacological activity.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (S)-2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-butanoic acid is used as a subject of study to understand its structure-activity relationship and to potentially optimize its pharmacological properties for more effective treatment of targeted disorders. (S)-2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-butanoic acid's unique structure, with its multiple functional groups, offers opportunities for further modification and improvement to enhance its therapeutic potential.
Used in Drug Development:
(S)-2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-butanoic acid is utilized in drug development as a lead compound for the creation of new medications targeting central nervous system disorders. Its benzodiazepine backbone and diverse functional groups provide a foundation for the design of more potent and selective drugs with fewer side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 688020-76-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,8,0,2 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 688020-76:
(8*6)+(7*8)+(6*8)+(5*0)+(4*2)+(3*0)+(2*7)+(1*6)=180
180 % 10 = 0
So 688020-76-0 is a valid CAS Registry Number.
688020-76-0Relevant academic research and scientific papers
SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT
-
Page/Page column 147, (2008/06/13)
The invention relates to CGRP antagonists of general formula (I), in which A, U, V, W, X and R1 to R 3 are as defined in claim 1, the tautomers, diastereomers, enantiomers, hydrates, mixtures, salts, hydrates of the salts, in particular the physiologically-acceptable salts thereof with inorganic or organic acids, medicaments containing said compounds and the use and methods for production thereof.
